Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000215172 | SCV000270458 | likely benign | not specified | 2015-09-28 | criteria provided, single submitter | clinical testing | p.Ser118Ser in exon 05 of MYH7: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 3/16512 South Asia n chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstit ute.org; dbSNP rs368925624). |
Color Diagnostics, |
RCV000771954 | SCV000904908 | likely benign | Cardiomyopathy | 2018-10-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000875733 | SCV001018202 | likely benign | Hypertrophic cardiomyopathy | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000215172 | SCV002571796 | likely benign | not specified | 2022-08-06 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336595 | SCV002618738 | likely benign | Cardiovascular phenotype | 2018-04-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics, |
RCV000215172 | SCV001925039 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701791 | SCV001929640 | likely benign | not provided | no assertion criteria provided | clinical testing |